Incidence of Pregnancies and Births With Spina Bifida in Denmark in 2008-2014
1 other identifier
observational
350,000
1 country
1
Brief Summary
Neural tube defects cover a group of severe embryo malformations such as anencephaly and spina bifida. The most severe forms of spina bifida causes numerous disabilities that demand lifelong treatment by a team consisting of primarily neurosurgeons, pediatricians, obstetricians, pediatric neurologists, pediatric urologists, gastroenterologists, psychologists and social workers. The disabilities involve morbidity such as decreased motor and sensory function caudal to the lesion, hydrocephalus, scoliosis, bladder and bowel incontinence as well as increased mortality. In 2004, the Danish Health Authorities introduced new guidelines for fetal diagnostics. These represented a change of paradigm stating that all pregnant women should be offered a prenatal examination including an ultra sound scan in week 12-13 of gestation (including risk estimation of chromosomal diseases) as well as in week 19 of gestation (scanning primarily for malformations). The examination program was not elaborated to eradicate diseases but to support the reproductive autonomy of the pregnant women, including the possibility to seek for termination of the pregnancy in the case of severe disease in the fetus. Severe spina bifida is one of the malformations that can be diagnosed with the ultra sound scan in week 19, and since the implementation of the new guidelines from the Danish Health Authority a study by this research group has shown decreased birth incidence at least in the Western part of Denmark. It is still unknown what has caused this decrease as is the exact number of pregnancies and births complicated by spina bifida in the child; similarly it is unclear whether this decline is a regional or if it is only a Danish phenomenon. By extraction of data from the Danish Fetal Database ("FØTOdatabasen") which includes information of all 60.000 pregnancies in Denmark annually, the purpose of this register study is to investigate the incidence of pregnancies complicated by prenatal diagnosis of spina bifida in Denmark from 2008 and on, as well as the pregnancy outcome in these cases (including termination of pregnancy). Furthermore results will be compared to results obtained by collaborative partners in Sweden and hopefully also in Saudi Arabia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 11, 2016
CompletedFirst Posted
Study publicly available on registry
February 19, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2017
CompletedMarch 8, 2016
March 1, 2016
9 months
February 11, 2016
March 7, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of spina bifida
8 years
Study Arms (1)
Pregnant women in Denmark
Pregnant women in Denmark participating in prenatal screening. This counts for approximately 50000 pregnancies/year and covers \>95% of all pregnancies nationally.
Eligibility Criteria
FØTOdatabasen is a national fetal medicine database, which includes information on maternal characteristics: age, parity, BMI, ethnicity, smoking status, diabetes status (from 2014), and on the pregnancy: mode of conception, result of first trimester risk assessment for chromosomal anomalies, biometric data, ICD10-codes for any prenatally diagnosed malformation. It links data regarding each pregnancy with postnatal outcome received from the Danish Cytogenetic Registry, the National Patient Registry and the National Birth Registry. FØTOdatabasen includes \>95% of all pregnancies in Denmark with due date from 1. January 2008 and onwards. The data completeness is high, with missing data \<1% for pregnancy outcome, \<1% for smoking status, and \<3% for mode of conception
You may qualify if:
- Pregnant women, participating in prenatal screening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aarhus University Hospitallead
- Karolinska University Hospitalcollaborator
Study Sites (1)
Department of Gynecology and Obstetrics, Aarhus university Hospital
Aarhus N, 8200, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Olav B. Petersen, MD, ph.d
Aarhus University Hospital
- STUDY CHAIR
Mikkel M. Rasmussen, MD, ph.d
Aarhus University Hospital
- PRINCIPAL INVESTIGATOR
Charlotte R. Bodin, Bsc.med
Aarhus University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical and research year student
Study Record Dates
First Submitted
February 11, 2016
First Posted
February 19, 2016
Study Start
February 1, 2016
Primary Completion
November 1, 2016
Study Completion
January 1, 2017
Last Updated
March 8, 2016
Record last verified: 2016-03
Data Sharing
- IPD Sharing
- Will share